A) University of Pennsylvania ("PENN") and the Children's Hospital of Philadelphia ("Children's Hospital")
B) CCA's Nanoscale Particle Complex (“NPC”) technology
C) a phospholipid-based nano-encapsulation drug delivery system
D) anti-cancer /general immunity modular pharmaceutical products and other pharmaceuticals (including oral, intra-nasal, and sublingual products (such as vaccines, anti-inflammatory products, analgesics, and anti-dementia, hepatic detoxification, and cardiovascular products) and topical products (such as anti-inflammatory products, analgesics, anti-infective agents (bacterial, viral and fungal) basal cell treatments and vaccines, and melanoma treatments and vaccines)).
E)Michael W Fountain
F)Tocopherol
G)Everything
All answers can be found in government and public documents